Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant

ABSTRACT: Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant

PROVIDER: PRJNA555995 | ENA |

REPOSITORIES: ENA